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The persistence of a functional pool of lympho-
cytes is critical to keeping the adaptive immune 
system ready to respond to pathogens and trans-
formed cells. It is currently believed that main-
tenance of functional T cells in the periphery is 
an active process. However, the factors involved 
in regulating T cell homeostasis and functional 
reactivity are poorly understood, in part because 
these  factors  may  vary  depending  on  the  T   
cell subset (e.g., CD4 or CD8 populations), 
their differentiation state (naive, effector, or 
memory), and the overall size of T cell pool 
(lymphoreplete  versus  lymphopenic;  Marrack 
and Kappler, 2004).
For CD8 T cells, several studies compared 
the recovery of donor cells from class I MHC 
(MHC I)–deficient hosts to that from WT hosts, 
concluding that T cell interaction with MHC 
is critical for the survival of naive T cells, but 
irrelevant for memory T cells (Tanchot et al., 
1997; Nesic ´ and Vukmanovic ´, 1998; Murali-
Krishna et al., 1999; Sprent and Surh, 2002; 
Markiewicz et al., 2003; Surh and Sprent, 2005). 
However, a feature of these studies is the reliance 
on analysis of lymphopenic hosts to determine 
survival of naive CD8 T cells. As subsequent 
studies have indicated, lymphopenic conditions 
increase  availability  of  homeostatic  cytokines 
and can also drive proliferation and differentiation 
of naive T cells, through lymphopenia-driven 
homeostatic proliferation, which involves TCR 
engagement with self-peptide–MHC ligands 
(Ernst et al., 1999; Kieper and Jameson, 1999; 
Goldrath et al., 2002; Jameson, 2002, 2005; 
Marrack and Kappler, 2004). Consideration of 
the impact of lymphopenia in previous studies 
has  reopened  the  debate  about  the  role  of 
MHC molecules in maintenance of both CD4 
and CD8 T cells (Jameson, 2002, 2005; Dorfman 
and  Germain,  2002;  Germain  et  al.,  2002; 
Grandjean et al., 2003; Martin et al., 2006). 
  Indeed, studies suggest that, in the absence of 
class II MHC (MHC-II) molecules, naive CD4 
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Previous studies have suggested that naive CD8 T cells require self-peptide–major histo-
compatability complex (MHC) complexes for maintenance. However, interpretation of such 
studies is complicated because of the involvement of lymphopenic animals, as lymphopenia 
drastically alters naive T cell homeostasis and function. In this study, we explored naive 
CD8 T cell survival and function in nonlymphopenic conditions by using bone marrow 
chimeric donors and hosts in which class I MHC expression is absent or limited to radio-
sensitive versus radioresistant cells. We found that long-term survival of naive CD8 T cells 
(but not CD4 T cells) was impaired in the absence of class I MHC. However, distinct from 
this effect, class I MHC deprivation also enhanced naive CD8 T cell responsiveness to low-
affinity (but not high-affinity) peptide–MHC ligands. We found that this improved sensi-
tivity was a consequence of up-regulated CD8 levels, which was mediated through a 
transcriptional mechanism. Hence, our data suggest that, in a nonlymphopenic setting, 
self-class I MHC molecules support CD8 T cell survival, but that these interactions also 
attenuate naive T cell sensitivity by dynamic tuning of CD8 levels.
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bound to its intracellular domain (Zamoyska et al., 2003) and 
CD8’s ability to stabilize interactions between MHC-I and 
TCR (Garcia et al., 1996; Schott and Ploegh, 2002). CD8 
expression levels are known to affect TCR signaling thresh-
olds (Holler and Kranz, 2003; Maile et al., 2005; Feinerman 
et al., 2008), and it has been suggested that CD8 expression 
is not set in the thymus, but dynamically modulated in the 
periphery, contributing to the tolerance of naive cells and the 
prevention of redundant killing by effector cells (Rocha and 
von Boehmer, 1991; Maile et al., 2005; Xiao et al., 2007). 
Recently, Park et al. (2007) reported that signals of common 
-chain  cytokines,  including  IL-2,  -7,  and  -15,  increase 
CD8 expression at the transcriptional level. This action is 
impaired by signals via TCR, strikingly reflecting the TCR 
signal intensity (Park et al., 2007). However, the role of   
self-peptide–MHC-I  for  the  CD8  tuning  has  not  been   
directly examined.
In this study, we characterized the survival and function 
of naive CD8 T cells in MHC-I–deficient hosts under lym-
phoreplete condition. To allow for transfer of cells across an 
MHC-I mismatch barrier, we used BM chimeras for both 
donors and hosts in these experiments. We report that the 
long-term survival of naive CD8 T cells was impaired in 
MHC-I–deficient condition. However, naive CD8 T cells 
deprived of contact with MHC-I molecules showed pheno-
typic  and  functional  evidence  of  retuning.  This  included   
elevated transcription and cell surface expression of CD8, 
which we show leads to enhanced responsiveness to low-
  affinity TCR ligands. These data demonstrate that engagement 
with self-MHC class I molecules, in a lymphoreplete envi-
ronment, leads to divergent effects on CD8 T cell survival 
versus functional sensitivity.
RESULTS
Loss of MHC-I availability in a lymphoreplete setting leads 
to reduced long-term maintenance of naive CD8 T cells
Normal lymphocytes are rejected when transferred to un-
manipulated MHC-I–deficient mice (including KbDb/, 
2m/, and KbDb/2m/ animals) because of residual 
host CD8 T cells that respond vigorously to WT levels of 
MHC-I (Ljunggren et al., 1995, 1996; Vugmeyster et al., 
1998; Boyman et al., 2006). Hence, we initially studied BM 
chimeric hosts that are partially deficient of “classical” class I 
MHC molecules (referred to as MHC-I) and are expected to 
be tolerant to WT donor cells. This included KbDb/ → 
WT and reciprocal WT → KbDb/ chimeras (WT → WT 
chimeras were also used as a control chimeric host). CFSE-
labeled B6 donor cells were transferred and, 30 d later, ana-
lyzed for maintenance and division. Naive (CD44lo) donor 
CD8 T cells remained CFSEhi (Fig. 1 a) and were maintained 
(Fig. 1 b) equivalently in all hosts. As expected, the absolute 
number of donor naive CD4 cells recovered was comparable 
in all hosts, indicating that these chimeras were tolerant to 
MHC-I–positive donor cells (Fig. 1 b). Importantly, the lack 
of proliferation of the donor naive T cells confirms that the 
hosts are functionally lymphoreplete. These data also suggest 
T cells survive efficiently in lymphoreplete hosts (Clarke and 
Rudensky, 2000; Dorfman et al., 2000), but decline in a lym-
phopenic environment (Takeda et al., 1996; Brocker, 1997; 
Rooke  et  al.,  1997;  Witherden  et  al.,  2000;  Labrecque   
et al., 2001; Polic et al., 2001; Dorfman and Germain, 2002;   
Germain et al., 2002; Jameson, 2002, 2005; Grandjean et al., 
2003;  Martin  et  al.,  2006).  Importantly,  there  have  been   
no  similar  comprehensive  studies  of  the  requirement  for 
MHC-I in maintenance of CD8 T cells under nonlympho-
penic conditions. This is due, at least in part, to complications 
in adoptive transfer approaches; WT T cells transferred into 
MHC-I–deficient recipients are rejected because of a small 
host CD8 T cell pool highly responsive to MHC-I molecules 
(Ljunggren et al., 1995, 1996; Vugmeyster et al., 1998), a 
problem that is not encountered in transfer of WT cells in 
MHC-II–deficient hosts.
A related issue is the identity of the MHC-expressing host 
cell populations that are required for T cell survival. Data 
from Brocker (1997) suggested that MHC-II expression on 
DCs was essential for maintenance of CD4 T cells, and that 
restricted expression of MHC-I on DCs was sufficient for 
homeostasis of CD8 T cells (Gruber and Brocker, 2005). 
However, studies using BM chimeras suggested that class I 
expression on either radiosensitive or radioresistant cells was 
sufficient for maintenance of CD8 T cells (Markiewicz et al., 
2003). Once again, however, interpretation of these data is 
complicated by the use of lymphopenic recipient animals.
Recent studies suggest self-peptide–MHC molecules may 
have more important effect on T cell function than simple 
survival. Stefanová et al. (2002) showed that the exposure of 
naive CD4 T cells in MHC-II–deprived condition results in 
an immediate reduction in sensitivity to foreign antigens as-
sociated with the loss of basal phosphorylation and polariza-
tion of TCR. Likewise, in the absence of MHC-II ligands, 
memory CD4 T cells were maintained, yet became function-
ally impaired (as measured by skin graft rejection; Kassiotis et 
al., 2002; De Riva et al., 2007). More recently, Fischer et al. 
(2007) showed a progressive loss of motility by naive CD4 T 
cells  transferred  into  MHC-II–deficient  hosts,  leading  to 
failed  engagement  with  cognate  antigen–bearing  DCs  in 
vivo.  However,  polar  opposite  results  have  also  been  re-
ported. Naive CD4 T cells deprived of the contact with 
MHC-II were shown to exhibit a more vigorous Ca2+ influx 
after TCR triggering with high-affinity ligands (Smith et al., 
2001), in parallel with decreased levels of CD5, which acts as 
a negative regulator of TCR signal (Tarakhovsky et al., 1995; 
Azzam et al., 1998, 2001; Smith et al., 2001). In addition,   
after a long-term maintenance in MHC-II–deficient condi-
tion, CD4 T cells acquired reactivity to syngeneic skin grafts 
(Bhandoola et al., 2002). Here again, the fact that experi-
ments were performed under lymphopenic (Bhandoola et al., 
2002) versus lymphoreplete (Fischer et al., 2007) conditions 
may contribute to these apparently contradictory results, but 
this has not been directly addressed.
CD8 is a coreceptor required to enhance the sensitivity of 
CD8 T cells, at least in part because of the activity of Lck JEM VOL. 206, September 28, 2009 
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source of donor cells. Because of availability of MHC-I on 
thymic stroma, these animals generate a pool of MHC-I–
  restricted CD8 T cells, but the donor cells themselves are 
KbDb/. As MHC-deficient hosts, we used unmanipulated 
KbDb/ or KbDb/ → KbDb/ chimeras. Alternatively, 
we used KbDb/ → WT and WT → KbDb/ hosts to limit 
MHC-I  expression  to  radioresistant  versus  radiosensitive 
cells, respectively. Because KbDb/ cells are present in all of 
these hosts, we expected that they would be tolerant of the 
KbDb/ donor cells.
At 30 d after transfer into these various hosts, CD44lo 
(naive) phenotype donor CD8 T cells retained high levels of 
CFSE, indicating a lack of proliferation (Fig. 1 c). However, 
maintenance  of  donor  CD8  T  cells  was  reduced  in  fully 
MHC-I–deficient  hosts  compared  with  KbDb/  →  WT 
hosts (in which MHC-I is expressed by radioresistant cells; 
Fig. 1 d). This impaired persistence was not observed for the 
cotransferred CD4 T cells, arguing against rejection or some 
generalized decrease in donor cell survival in KbDb/ hosts. 
Nevertheless, the persistence of CD8 T cells at this frequency 
for 30 d in the absence of MHC-I is greater than might be 
predicted from previous studies (conducted in lymphopenic 
conditions) that suggested almost complete loss of naive CD8 
T cells within 14 d after transfer into MHC-I–deficient   
mice (Tanchot et al., 1997; Nesic ´ and Vukmanovic ´, 1998; 
Markiewicz et al., 2003; Hao et al., 2006). We used KbDb/ → 
WT chimeras as a MHC-I–expressing host to avoid potential 
NK rejection concerns that would be associated with trans-
fer into WT hosts. Surprisingly, we observed rejection of 
KbDb/ donor cells in WT → KbDb/ hosts (unpublished 
data); thus, these chimeras were excluded in further studies.
The half-life of naive CD8 T cells in MHC-I–deficient   
environments has been estimated to be between 2 and 7 d 
  (Tanchot et al., 1997; Dorfman and Germain, 2002; Markiewicz 
et al., 2003), whereas studies in which TCR expression was 
postthymically ablated suggested a naive CD8 T cell half-life of 
16–19 d (Labrecque et al., 2001; Polic et al., 2001). As previ-
ously discussed, interpretation of these studies is complicated by 
lymphopenia in the host animals. To track how host MHC-I 
influences naive CD8 T cell survival in lymphoreplete hosts, we 
determined the decay rate of donor KbDb/ T cells in KbDb/ 
and KbDb/ → WT hosts until 60 d after transfer. Donor CD8 
(and CD4) T cells were detected above background at all time 
points (Fig. 2 a); however, there was a clear difference in the 
maintenance of the donor CD8 pool in the MHC-I–deficient 
and –sufficient hosts. Although we estimated a half-life of 21 d 
for polyclonal CD8 T cells in KbDb/ → WT hosts, the half-
life was reduced to 10 d in KbDb/ hosts (Fig. 2 b), which   
is consistent with the data presented in Fig. 1 d. In contrast, the 
half-life for naive CD4 T cells was similar in the two hosts (Fig. 
2b). Our estimated half-lives for CD4 T cells suggested a faster 
decay rate than those reported in some other studies (Hataye   
et al., 2006; Polic et al., 2001). The reason for this difference is 
not clear, but does not appear related to use of chimeric hosts 
because we observed similar half lives using both chimeric and 
nonchimeric hosts (unpublished data), and our data are consistent 
that maintenance of naive CD8 T cells in animals was similar 
whether the predominant expression of MHC-I molecules 
was on radiosensitive or radioresistant cells. These findings 
match the conclusions of Markiewicz et al. (2003) tracking 
CD8 T cell persistence in lymphopenic hosts.
To determine the effect of complete class I deficiency   
on CD8 T cell maintenance, we altered the experimental   
approach. To exclude a role for MHC-I on donor cells them-
selves, we used T cells from KbDb/ → WT chimeras as the 
Figure 1.  Naive CD8 T cells persist without proliferation in BM 
chimeric hosts. Lymphocytes from WT mice (a and b) or purified KbDb/ 
lymphocytes from KbDb/ → WT BM chimeras (c and d) were stained 
with CFSE and injected i.v. (5 × 106/mouse) into intact WT (a and b) or 
KbDb/ (c and d) mice and various BM-chimeric recipients. 30 d after 
transfer, spleens and lymph nodes were harvested and analyzed by flow 
cytometry on individual mice. (a and c) CFSE dilution of CD8 T cells in  
the spleen of recipients 30 d after transfer. The outlined area represents 
CFSEhiCD44lo cells analyzed for the survival and numbers above indicate 
the percentage of cells in CD8 gate. (b and d) Recovery of CFSEhiCD44lo 
donor CD8 (left) and CD4 (right) T cells. Total donor cell numbers in the 
spleens and lymph nodes are shown. Data are mean ± SD. Results are 
representative of two independent experiments with at least three mice  
per group. *, P < 0.05; **, P < 0.01; ***, P < 0.001.2256 Self-MHC dictates naïve T cell sensitivity by CD8 tuning | Takada and Jameson
Previous studies have shown that TCR affinity to self-
peptide–MHC-I ligands (Kieper et al., 2004) or cross-reactivity 
with environmental ligands (Hao et al., 2006) can affect the 
homeostatic proliferation of T cells in lymphopenic condition, 
suggesting the different dependence on MHC requirement 
for homeostasis between clones. It was possible that the rapid 
decay rate of CD8 T cells in KbDb/ hosts led to selective 
survival of an oligoclonal pool of CD8 T cells, rather than 
with an overall average life span of peripheral naive T cells of   
5–8 wk, as has been reported previously (von Boehmer and 
Hafen, 1993; Tough and Sprent, 1994). To control for variabil-
ity in donor cell maintenance, we also assessed the ratio of donor 
CD8 to CD4 T cells in individual animals. As shown (Fig. 2c), 
the increased decay rate of CD8 cells in KbDb/ hosts also lead 
to a statistically significant difference in the donor CD8/CD4 
ratio compared with the KbDb/ → WT hosts.
Figure 2.  Impaired survival of CD8 T cells in the complete absence of MHC-I. Purified KbDb/ lymphocytes (Thy1.1) from KbDb/ → WT BM 
chimeras were transferred (3–5 × 106/mouse) to normal KbDb/ mice and KbDb/ → WT BM chimeras. (a) Detection of donor CD8 T cells by flow  
cytometry at day 60 after transfer (left and middle). (right) Background events detected by the same method in nontransferred WT mice. Numbers above 
the outlined area indicate the percentage of cells in the lymphocyte gate. (b and c) Mice were sacrificed at indicated time points and analyzed for the 
recovery of donor T cells from the spleen and lymph nodes. (b) Absolute number of Thy1.1+CD44loCD8 (left) and Thy1.1+CD44loCD4 (right) donor cells. 
Half-lives (t1/2) were calculated from regression lines (Hataye et al., 2006). (c) Combined results of two independent experiments. CD8/CD4 ratio was  
calculated before (R0) and after (R1) transfer into KbDb/ → WT BM chimeric or normal KbDb/ hosts. Difference of CD8/4 balance in donor cells  
between experiments was normalized by calculating R1/R0. (d) TCR V analysis of Thy1.1+CD44loCD8 cells at day 20 after transfer. Percentage of cells  
that stain positive for each V chain in total Thy1.1+CD44loCD8 cells is shown. The bars show the mean ± SD. All data other than c are representative  
of two independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001.JEM VOL. 206, September 28, 2009 
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the survival of naive T cells (Akashi et al., 1997; Jameson, 
2002, 2005; Marrack and Kappler, 2004; Surh and Sprent, 
2005), we analyzed expression of IL-7R on T cells exposed 
to partial or complete MHC-I deficiency. Although CD8 
and CD4 donor T cells exhibited comparable levels of IL-
7R when maintained in WT or partially MHC-I–deficient 
hosts (Fig. 3 a and Fig. S1), there was a significant and selec-
tive down-regulation of IL-7R on CD8 T cells recovered 
from KbDb/ and KbDb/ → KbDb/ hosts (Fig. 3 b and 
Fig. S2). Decreased IL-7R staining was observed as a 
slight,  but  uniform,  change  in  expression  level  on  the 
MHC-I–deprived CD8 T cell pool (Fig. S2), arguing against 
reflecting decay of the bulk population. Arguing against this 
explanation, however, we found similar overall TCR reper-
toire diversity among surviving CD8 T cells at day 20 after 
transfer in both KbDb/ and KbDb/ → WT hosts, a time 
point where more rapid decay of CD8 T cells in the KbDb/ 
host is already apparent (Fig. 2 d).
Phenotypic analysis suggests retuning of CD8 T cells  
in MHC-I–deficient environments
We  also  examined  how  MHC-I  deprivation  influences   
expression of key cell surface molecules on donor CD8 (and 
CD4) T cells. Because IL-7 signaling plays a critical role for 
Figure 3.  MHC-I–deprivation leads to phenotypic changes in naive CD8 T cells, suggestive of retuning. Lymphocytes from WT mice (a) or  
purified KbDb/ lymphocytes from KbDb/ → WT BM chimeras (b and c) were injected i.v. (3–5 × 106/mouse) into indicated recipients. (a and b) 30 d 
after transfer, donor naive CD8 and CD4 T cells in host spleens were detected by CFSE label and a CD44lo naive T cell marker. Surface expression of IL-7R, 
CD5, and coreceptors (CD8 or CD4) were analyzed. (c) At day 20 after transfer, spleens and lymph nodes were harvested from host mice, and CD8  
expression on CD44loCD8 donor cells (Thy1.1+) that stain positive for each V chain was analyzed. Data are presented as relative fluorescence intensity 
(RFI), indicating the expression which is normalized to the average of mean fluorescence intensity (MFI) in WT → WT hosts (a) or KbDb/ → WT hosts  
(b and c) defined as 100. Data are mean ± SD. Results are representative of two independent experiments with at least three mice per group. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001.2258 Self-MHC dictates naïve T cell sensitivity by CD8 tuning | Takada and Jameson
tant cells, the effect was more pronounced in the hosts where 
radioresistant cells are deficient of MHC-I (Fig. 3 a and Fig. S1), 
showing a similar extent of elevated CD8 expression as cells 
recovered from hosts that completely lack MHC-I (Fig. 3, a 
and b, Fig. S1, and Fig. S2). CD4 expression on cotransferred 
CD4 T cells was not markedly altered in any host (Fig. 3, a 
and b, Fig. S1, and Fig. S2). The CD8 levels were increased 
to a maximum of 125% on CD8 T cells in MHC-I–deficient 
hosts. This elevation in CD8 expression in KbDb/ hosts 
was observed for donor cells bearing different V elements 
(Fig. 3 c), implying that T cells of diverse specificity up-regulated 
the  coreceptor  under  these  conditions.  On  the  other   
hand, TCR expression levels did not increase on donor T 
cells in MHC-I–deficient hosts (Fig. 3 c). These changes 
in CD5, CD127, and CD8 expression were also seen in 
nonchimeric KbDb/ hosts at day 20 (Fig. 2 b, Fig. 3 c, 
and not depicted).
progressive loss of IL-7Rhigh cells. We also studied expres-
sion  of  CD5,  a  monomeric  glycoprotein  that  negatively 
regulates the signaling through TCR and whose level on 
naive CD4 T cells has been observed in association with   
recent exposure to self-MHC molecules (Polic et al., 2001; 
Smith et al., 2001; Fischer et al., 2007). Similar to IL-7R, 
CD5  levels  were  substantially  reduced  on  CD8  T  cells   
recovered from KbDb/ hosts (Fig. 3, a and b, Fig. S1, and 
Fig. S2). These data are consistent with studies on MHC-II–
deprived CD4 T cells, which were also shown to down-
regulate CD5 (Polic et al., 2001; Smith et al., 2001; Fischer 
et al., 2007).
In contrast to these trends, CD8 itself was up-regulated 
on CD8 T cells isolated from hosts that were partially or 
completely deficient of MHC-I (Fig. 3, a and b). Although 
an  increase  in  CD8  expression  was  observed  even  when 
MHC-I was available on either radiosensitive or radioresis-
Figure 4.  MHC-I deprivation causes enhanced CD8 T cell reactivity to low-affinity TCR ligands in vitro. Purified CD8 T cells from  
KbDb/Rag/OT-I Tg → WT chimeras were CFSE stained and transferred (3 × 106/mouse) to KbDb/ → KbDb/ or KbDb/ → WT BM chimeric hosts.  
All experiments were performed 14 d after transfer. (a) Spleens were harvested from recipients and analyzed for the expression of CD5 and CD8 on the 
surface of donor OT-I cells by flow cytometry. Data are presented as relative fluorescence intensity (RFI) normalized to the average of MFI in KbDb/ → 
WT hosts. (b–d) Host spleen cells were cultured with irradiated WT splenocytes pulsed with different concentrations of OVAp (0–106 pM; b and d) or indicated 
peptides (c). Cells were analyzed for the expression of CD69 (b and c) or intracellular TNF (d). (e) Recipients were injected i.v. with WT DCs (106/mouse) 
pulsed or nonpulsed with OVAp. 18 h after DC injection, donor cells in the spleens (SPL) and lymph nodes (LN) were analyzed for the expression of CD69. 
The percentage of donor cells with CD69hi phenotype is shown (b–d). Data represent mean ± SD. Data are representative of two to four independent  
experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001.JEM VOL. 206, September 28, 2009 
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agonist G4 (Fig. 4 c). This finding suggests that MHC-I depri-
vation leads to enhanced reactivity toward weak agonists,   
although it was not sufficient to induce overt reactivity to-
ward self-peptide–MHC ligands (as determined by the mini-
mal response toward -Cat and endogenous peptide–MHC 
complexes displayed by “no-peptide” control B6 APCs).
Although  others  have  used  CD69  up-regulation  to 
  determine altered T cell sensitivity after MHC-deprivation 
(Bhandoola et al., 2002), one study reported that MHC-II 
deprivation of CD4 T cells did not impact sensitivity as mea-
sured by CD69 induction, but did impair cytokine produc-
tion (Stefanová et al., 2002). We also assayed induction of 
TNF after in vitro stimulation. Similar to CD69 induction, 
production of TNF in response to the strong agonist OVAp 
was not affected by MHC-I deprivation (Fig. 4 d). Stimula-
tion using the G4 peptide induced only weak and variable 
TNF production (unpublished data), and thus this assay could 
not be used reliably to measure functional sensitivity to this 
low-affinity ligand.
Together, these data suggest that preventing the engage-
ment of CD8 T cells with self-peptide–MHC-I (in a non-
lymphopenic environment) did not impact overall TCR 
sensitivity of the OT-I CD8 T cells, but did selectively en-
hance their responses to low-affinity TCR ligands. However, 
our data suggest that these changes in sensitivity did not extend 
to overt reactivity toward self-peptide–MHC ligands.
Fischer et al. (2007) found that MHC-II deprivation of 
CD4 T cells had little impact on their functional sensitivity in 
vitro, but led to a dramatic impairment of responsiveness in 
vivo caused by compromised motility, which prevented en-
gagement of DCs bearing strong agonist ligands. To explore 
whether analogous changes were occurring in the CD8 T cell 
system, we maintained KbDb/ OT-I T cells in KbDb/ → 
KbDb/ or KbDb/ → WT BM chimeras for 14 d, and 
then injected these animals with WT DCs that were pulsed 
with OVAp (or PBS). The response of the OT-I pool was 
assessed by CD69 up-regulation 18 h later (Fig. 4e). A robust 
response was induced in both host environments, and there 
was no indication that the MHC-I deprived OT-I cells showed 
a reduced reactivity toward antigen-bearing DC—indeed, 
there was a trend (although not statistically significant) toward 
the opposite conclusion. In contrast to the findings for   
MHC-II–deprived OT-II T cells (Fischer et al., 2007), re-
moval of MHC-I ligands did not impair OT-I sensitivity to-
ward high affinity antigen-bearing DCs in vivo.
We concluded that both in vitro and in vivo responsive-
ness of CD8 T cells to stimulation with potent peptide–MHC 
ligands did not change dramatically, even after long-term   
exposure of CD8 T cells to MHC-I–deficient condition. 
This was despite the phenotypic alterations (CD5 decrease 
and CD8 increase) indicative of T cell retuning. Importantly, 
our in vivo studies did not observe the marked impairment   
in reactivity described for MHC-II–deprived CD4 T cells 
(Fischer et al., 2007). At the same time, we found that   
the  ability  of  CD8  T  cells  to  qualitatively  discriminate   
antigenic  stimulation  was  altered  in  MHC-I–deficient   
CD8 T cells are hyperreactive to low-affinity ligands  
after long-term exposure to MHC-I–deficient condition
The  changes  in  CD5  and  CD8  expression  after  MHC-I   
deprivation might alter CD8 T cell reactivity. To test this,   
we generated KbDb/ OT-I CD8 T cells (using KbDb/ 
Rag/ OT-I → WT BM chimeras) as a source of cells with 
known TCR specificity. Mature OT-I CD8 T cells from 
these animals were then transferred into KbDb/ → KbDb/ 
and KbDb/ → WT BM chimeras, which were completely 
and partially MHC-I deficient, respectively. Based on the 
half-life determinations for polyclonal CD8 T cells (Fig. 2), 
we anticipated that OT-I cells would be maintained in both 
hosts for at least 14 d, and indeed we observed no differences 
in OT-I T cell numbers in the two hosts by this time point 
(not  depicted).  Also,  similar  to  our  data  with  polyclonal   
CD8 T cells, OT-I cells maintained in completely KbDb/ 
hosts showed increased CD8 expression and decreased CD5 
levels, whereas TCR expression levels were unchanged   
compared with KbDb/ → WT controls (Fig. 4 a). We have 
previously defined the response of OT-I T cells to the strong 
agonist peptide OVA peptide (OVAp), as well as to weak   
agonist variants of OVAp (Jameson et al., 1993; Hogquist   
et al., 1994; Rosette et al., 2001). To test functional reactiv-
ity of these cells in vitro, OT-I cells from both hosts were 
stimulated with B6 splenocytes coated with various pep-
tides, and up-regulation of the activation marker CD69   
was monitored.
Studies using CD4 T cells have led to contradictory con-
clusions, with some studies suggesting MHC-II deprivation 
leads to enhanced functional reactivity (Smith et al., 2001; 
Bhandoola et al., 2002), whereas other works suggest it causes 
reduced sensitivity for cognate antigens (Kassiotis et al., 2002; 
Stefanová et al., 2002; De Riva et al., 2007). Distinct from 
either of these findings, we found that the complete MHC-I 
deprivation  had  no  effect  on  the  functional  sensitivity  of   
OT-I cells toward OVAp, which is a high-affinity peptide for 
the OT-I TCR (Jameson et al., 1993; Hogquist et al., 1994), 
as determined by a dose-response assay (Fig. 4 b).
On the other hand, it has been proposed that engagement 
with self-peptide–MHC may tune the activation thresholds 
of T cells, to avoid autoreactivity and/or to discriminate the 
quantitative or qualitative differences of antigens (Grossman 
and Paul, 2001). Therefore, we asked whether host MHC-I 
environment can affect the donor T cell sensitivity to various 
strengths of TCR stimulation in vitro. We tested two variants 
of the OVAp, termed N6 and G4, which have strong and 
weak agonist activity, respectively, for OT-I (Jameson et al., 
1993; Hogquist et al., 1994; Rosette et al., 2001). In addition, 
we tested the peptide -Cat, which encodes a naturally   
occurring TCR antagonist for the OT-I TCR (Santori et al., 
2002),  to  determine  if  reactivity  to  this  self-peptide  was   
altered after MHC-I deprivation.
Although no change in response to the strong agonist 
peptide N6, or the antagonist peptide -Cat were noted (Fig. 
4 c), we found that MHC-I–deprived OT-I cells consistently 
showed an improved functional response toward the weak 2260 Self-MHC dictates naïve T cell sensitivity by CD8 tuning | Takada and Jameson
Figure 5.  CD8 T cell retuning occurs rapidly after MHC-I deprivation. (a-c, e, and f) Purified CD8 T cells from WT OT-I Tg mice (Thy1.1) were trans-
ferred (3 × 106/mouse) to WT or KbDb/ mice. 1 d (a–c) or 2 h (e and f) after transfer, host spleen cells or pooled lymph node cells were analyzed for the 
phenotype of donor OT-I cells (a and e) or were stimulated with irradiated WT splenocytes pulsed with different concentrations of OVAp (0–106 pM; b) or 
indicated peptides (c and f). (d) Purified CD8 T cells from KbDb/Rag/OT-I Tg → WT chimeras were CFSE stained and transferred (3 × 106/mouse) to 
KbDb/ → KbDb/ or KbDb/ → WT BM chimeric hosts. 1 d later, host mice were injected (i.v.) with WT DCs (106/mouse) that were pulsed or nonpulsed 
with OVAp. 18 h after DC injection, donor cells in the spleens (SPL) and lymph nodes (LN) were analyzed by flow cytometry. The percentage of donor  
cells with CD69hi phenotype after stimulation is shown (b-d and f). (g and h) Purified OT-I cells with different congenic markers (Thy1.1+Thy1.2+ and 
Thy1.1+Thy1.2) were separately transferred (4–5 × 106/mouse) to WT and KbDb/ mice. Cells were CFSE-labeled before transfer in h. 36 h after transfer, 
lymph nodes cells from both hosts and irradiated B6 spleen cells were mixed at equal number and cultured with or without G4. Cells were analyzed for JEM VOL. 206, September 28, 2009 
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stained for cell surface CD69 or intracellular pc-Jun at 6 h (g) or for CFSE dye dilution at 48 h (h). In g, the percentage of CD69hi or pc-Jun+ CD8 T cells 
was determined, and the background value (from control cultures without G4 peptide) was subtracted. The response of the OT-I cells derived from the WT 
hosts was defined as 100. Data are representative of two independent experiments with three to four mice per group. Data in g represent combined re-
sults from three independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
 
conditions, with the cells showing enhanced reactivity to-
ward low-affinity ligands.
Short-term MHC-I deprivation leads to changes  
in phenotype and tissue-restricted changes in CD8  
T cell sensitivity
We had previously suggested that the discordant conclusions 
from studies on the effect of MHC-II deprivation on naive 
CD4 T cell responses might arise from differences in the   
time points studied (Hogquist et al., 2003). Thus, the study 
reporting that MHC-II deprivation diminished T cell sensi-
tivity assayed the cells within the first 24 h (Stefanová et al., 
2002), whereas other studies (which reported increased T 
cells sensitivity after MHC deprivation) looked at later time 
points (Smith et al., 2001; Bhandoola et al., 2002). These 
data could be consistent with an adaptation of T cells to the 
loss of self-peptide–MHC ligand engagement, which leads to 
a reversal in T cell sensitivity when comparing short- and 
long-term MHC deprivation (Hogquist et al., 2003).
To test this model, we modified our assays to examine 
OT-I  sensitivity  after  short-term  MHC-I  deprivation  for 
only 1 d. We examined the same adoptive transfer system 
(with KbDb/ OT-I cells placed into KbDb/ → KbDb/ 
or KbDb/ → WT BM chimeras). In addition, we took ad-
vantage of the fact that short-term transfer of WT cells into 
KbDb/ hosts does not result in their elimination (Fig. S3) 
and also assayed OT-I cells adoptively transferred into intact 
WT or KbDb/ hosts. In both settings, MHC-I deprivation 
led to loss of CD5 and IL-7R expression in the spleen and 
lymph nodes by 24 h after transfer (Fig. 5 a and not depicted). 
In the same hosts, CD8 levels were increased (by 25%), but 
this effect was more pronounced in the lymph nodes than in 
the spleen (Fig. 5 a and not depicted). These data suggested 
that the phenotypic adaptation of CD8 T cells to MHC-I 
deprivation occurs rapidly and, unexpectedly, that changes in 
CD8 expression were most pronounced in the lymph node.
To assess the impact which MHC-I deprivation for 24 h 
had on functional sensitivity, we again tested responses to 
OVAp and its variants. As with cells deprived of MHC-I for 
14 d, there was no change in responses to the high-affinity 
OVAp ligand, which were measured in vitro (Fig. 5, b and c) 
or in vivo (Fig. 5 d). However, reactivity to G4 peptide-
coated APC was enhanced (Fig. 5 c). Interestingly, this effect 
was detected in OT-I cells derived from the lymph nodes, 
but not from the spleen (Fig. 5 c).
These data suggest that sensory adaptation of CD8 T cells 
deprived of MHC-I takes place rapidly, within 1 d. It was 
possible that even this time frame was too long to observe 
rapid changes in CD8 T cell sensitivity. Studies with CD4 T 
cells suggested that loss of contact with MHC-II molecules 
for  as  little  as  a  few  hours  was  sufficient  to  compromise   
functional reactivity (Stefanová et al., 2002). We also studied 
OT-I cells 2 h after adoptive transfer into B6 versus KbDb/ 
hosts. At this time point, no consistent changes in expression 
of CD5 or CD8 were observed, and no changes in OVAp or 
variant peptide reactivity were detected (Fig. 5, e and f).
To extend these studies, we used additional functional   
assays. First, we tested whether the enhanced responses of 
MHC-I–deprived OT-I cells would be observed in the pres-
ence of normal OT-I cells. Congenically marked OT-I cells 
were transferred into class I–deficient or normal hosts, and   
36 h later the two populations were pooled and stimulated 
with G4 peptide in vitro. Because both normal and MHC-I–
  deprived OT-I cells are stimulated in the same culture, this 
assay controls for potential differences in APC populations 
and allows for direct comparison of the OT-I cell responses. 
Consistent with our previous studies, G4/Kb induced CD69 
expression was significantly enhanced on OT-I cells recov-
ered from MHC-I–deficient hosts (Fig. 5 g). We also investi-
gated induction of signal transduction intermediates. In an 
earlier study, we characterized induction of phosphorylated 
c-Jun (pc-Jun) by G4/Kb stimulation OT-I cells (Rosette et al., 
2001). Analysis of this response also revealed an enhanced   
response by MHC-I deprived OT-I cells (Fig. 5 g). Both of 
these assays monitored early activation responses, and we also 
tested proliferation, as a late functional response. Using a 
CFSE dye dilution assay, we observed similar proliferative 
potential of OT-I cells derived from either normal or MHC-I–
deficient environments (Fig. 5 h). This result might suggest 
that the effects of MHC-I deprivation do not affect all responses 
equally, and/or that these effects are transient and are lost 
during longer term functional assays. This issue is explored 
further in the Discussion.
Hence,  our  studies  suggested  that  the  phenotypic  and 
functional changes associated with MHC-I deprivation of 
CD8 T cells arose between 2 and 24 h (and was maintained 
for at least 14 d), and led to enhancement of early functional 
responses to low-affinity ligands.
Enhanced reactivity of MHC-I–deprived T cells  
is attributable to increased CD8 levels
Our studies showed that OT-I T cell transfer into MHC-I–
deficient hosts caused both enhanced reactivity to the weak 
agonist G4/Kb and an increase in CD8 expression levels (Figs. 
4 and 5). Previous studies have suggested that changes in 
CD8 expression or accessibility cannot ably affect T cell sen-
sitivity and ligand binding, especially for low-affinity peptide–
MHC ligands (Jameson et al., 1994; Holman et al., 2005; 
Daniels et al., 2006; Park et al., 2007; Xiao et al., 2007; 
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2006), these data suggest that low-affinity ligand engagement 
and/or reactivity is strongly influenced by the availability of 
the CD8 coreceptor. However, the OT-I response to OVAp 
does involve CD8 because stimulation of OT-I cells with 
low  doses  of  OVAp  is  highly  sensitive  to  CD8  blockade   
(Fig. S4 c), indicating that this blockade becomes inefficient 
when TCR stimulation is in excess.
Anti-CD8  antibody  (clone  53–6.7)  showed  blocking 
properties similar to 53–5.8 (Fig. S4, a and b), although they 
were slightly less effective (Fig. S4 c). These results might at 
first appear to contradict previous studies (including our own; 
Daniels and Jameson, 2000) showing that 53–6.7 enhances 
binding of cognate peptide–MHC tetramers to OT-I cells, 
whereas 53–5.8 blocks this binding. This can be explained by 
the capacity of the CD8 antibodies, under physiological con-
ditions, to induce capping and internalization of CD8; how-
ever, this will not occur in the flow cytometric assays used to 
measure peptide–MHC tetramer binding.
We next used the same approach to determine whether 
the enhanced CD8 expression levels seen on class I–deprived 
OT-I cells could account for their improved G4/Kb sensitiv-
ity. At 36 h after adoptive transfer, donor OT-I cells exhibited 
an 15% increase in CD8 expression when recovered from 
the lymph nodes of KbDb/ hosts compared with WT hosts 
(Fig. 6 c, no Ab), and the class I–deprived population showed 
enhanced reactivity toward G4 (Fig. 6 d, left). Treatment of 
the class I–deprived OT-I cells with low dose (1/102,400) of 
the  anti-CD8  antibody  resulted  in  available  CD8  levels   
being reduced to those found in the WT group (Fig. 6 c). 
Interestingly, this antibody treatment lead to a corresponding 
decrease in reactivity toward G4, resembling the response of 
OT-I cells from a WT host (Fig. 6 d, left). As expected, the 
response to high-dose OVAp was not affected by either the 
MHC-I expression status of the host, or partial CD8 block-
ade (Fig. 6, d right). Once again, the anti-CD8 antibody, 
53–6.7, yielded similar results (Fig. S4, d and e). Hence, these 
results suggested that MHC-I–deprivation led to enhanced 
OT-I T cell reactivity primarily because of increased CD8 
expression levels.
MHC-I deprivation regulates CD8 levels  
at the level of transcription
We next sought to determine the mechanism by which CD8 
levels are regulated by exposure to MHC-I molecules. At 
least two models can be imagined. In the first, MHC-I depri-
vation induces up-regulation (transcriptional or translational) 
of  CD8.  In  the  second  model,  encounter  of  CD8  with   
self-MHC-I molecules might lead to internalization of cell 
surface CD8.
To test these models, we developed an in vitro system 
where CD8 T cells could be more easily manipulated. T cells 
were cultured overnight in the presence or absence of anti-
Kb and anti-Db monoclonal antibodies. Interestingly, such 
treatment revealed that anti–MHC-I blockade led to up-reg-
ulation of CD8 and CD8 levels on CD8ve T cells from 
both polyclonal B6 (Fig. 7 a) and OT-I (Fig. 7 b) animals. 
deprivation only lead to an increase of 25% in CD8 levels 
(Figs. 4 a and 5 a) left open the question of its mechanistic 
relevance for the changes in T cell sensitivity. Thus, we char-
acterized how small changes in CD8 accessibility affected 
OT-I  reactivity  by  stimulating  freshly  isolated  OT-I  cells 
with G4 or OVAp in the presence of monoclonal anti-CD8 
(clone 53–5.8) antibodies titrated over a wide concentration 
range (Fig. 6 a). The same antibody was used as a fluorescent 
conjugate  to  determine  the  levels  of  “unblocked”  CD8,   
presumably available for ligand binding.
Although the OT-I response to high-dose OVAp peptide 
was barely affected by anti-CD8 blockade, the response to 
G4 peptide was drastically impaired, even when CD8 levels 
were only partially reduced (Fig. 6 b). As has been suggested 
by  other  studies  (Holler  and  Kranz,  2003;  Daniels  et  al., 
Figure 6.  CD8 up-regulation dictates the enhanced functional 
reactivity of MHC-I–deprived CD8 T cells. (a and b) Purified anti-
CD8 antibody (53–5.8; 0.5 mg/ml) was added at indicated titration to 
OT-I cell (Thy-1.1) suspension. Cells were then incubated with irradiated 
WT splenocytes pulsed with G4, OVAp or no peptide. After incubation, 
cells were stained with fluorochrome-conjugated anti-CD8 (53–5.8), and 
the levels of unblocked CD8 in the peptide-free group are shown as MFI 
relative to the cells nontreated with the blocking antibody (a). Response 
of OT-I cells to G4 and OVAp splenocytes is shown (b). Relative response 
indicates the percentage of CD69hi cells after the background value (no 
peptide control) was subtracted, and is shown relative to the mean of  
the “no antibody” group, which was defined as 100. (c and d) Purified OT-I 
cells (Thy1.1) were transferred (3–5 × 106/mouse) to WT or KbDb/ mice. 
36 h later, host lymph node cells were stimulated with irradiated WT sple-
nocytes pulsed or nonpulsed with G4 and OVAp. Cells from KbDb/ hosts 
were also stimulated in the presence of blocking anti-CD8 antibody 
diluted at 1:1,024,200 or 1:51,200, as indicated. (c) The levels of available 
CD8 were determined by staining the unstimulated group. (d) The  
capacity of the different cell populations to up-regulate CD69 in response 
to G4 (left) or OVAp (right) was determined and shown relative to the 
mean value obtained from OT-I cells from WT hosts (defined as 100). Data 
represent mean ± SD and are representative of two independent experi-
ments (a and b) or combined results from two independent experiments 
(c and d). *, P < 0.05; **, P < 0.01; ***, P < 0.001.JEM VOL. 206, September 28, 2009 
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cell treatment with anti-CD45.2 antibodies (which, like 
anti–class I antibodies, would bind all cells in the culture) 
did not affect CD8 expression levels (unpublished data). 
Thus, anti–class I antibody blockade appears to specifically 
up-regulate CD8 expression levels. Notably, the elevation in 
CD8 levels was completely abrogated when actinomycin D 
or cycloheximide (which inhibit transcription and protein 
synthesis, respectively) were added to the in vitro cultures. 
These data suggest that the increase in CD8 expression after 
MHC-I blockade is caused by altered transcription.
As an alternative assay for transcriptional regulation, we 
made use of a CD8a gene reporter transgenic strain termed 
E8I-CD4 (Park et al., 2007; Adoro et al., 2008). This well 
defined reporter expresses mouse CD4 under regulation of 
both the CD8a promoter and E8I enhancer elements, and is 
active in mature CD8CD4 thymocytes and peripheral CD8 
T cells (Park et al., 2007; Adoro et al., 2008). Hence, changes 
in transgenic CD4 expression would indicate altered CD8a 
gene expression, but, because CD4 does not engage MHC-I 
molecules,  CD4  internalization  would  not  be  affected  by 
MHC-I blockade. Thus, we cultured the spleen cells from 
E8I-CD4 Tg mice in vitro with anti-Kb and anti-Db antibod-
ies. As expected, the cell surface expression of endogenous 
CD8 and CD8 was enhanced by this treatment, but we 
also observed a significant increase in expression of the E8I-
CD4 transgene (whereas endogenous CD4, on other cells in 
the same culture, was not affected; Fig. 7 c). As expected,   
addition of actinomycin D or cycloheximide prevented these 
changes in E8I-CD4 (as well as CD8 and CD8) levels (un-
published data). Together, these data suggest that up-regulation 
of CD8 after deprivation of MHC-I contact is chiefly a result 
of increased CD8 transcription, operating (at least in part) 
through the E8I enhancer and/or CD8a promoter.
The capacity to induce up-regulation of CD8 expression 
by in vitro anti–MHC-I blockade also offered the opportunity 
to test whether this effect was reversible after reexposure to 
self-MHC ligands in vivo. OT-I CD8 T cells were cultured 
with or without anti-Kb/Db blockade, and then transferred 
into normal B6 hosts for 48 h. As expected, in vitro MHC-I 
blockade lead to CD8 and CD8 up-regulation (Fig. 7 d, 
Before), but this effect was lost after transfer into normal hosts 
(Fig. 7 d, 48 h). These data suggest that the increase in CD8 
expression induced by impaired MHC-I interactions is not a 
permanent feature of the cells, and that CD8 levels can “retune” 
once the T cells have the opportunity to reengage self-ligands.
DISCUSSION
The role of self-peptide–MHC class I complexes in survival 
and function of naive CD8 T cells has been difficult to ad-
dress. This is in large part caused by donor–host histoincom-
patibility issues, which have typically been solved by the use 
of lymphopenic hosts for adoptive transfer experiments. With 
the  understanding  that  lymphopenia-driven  homeostatic 
proliferation affects T cell proliferation, differentiation, and 
function (Dorfman and Germain, 2002; Germain et al., 2002; 
Grandjean et al., 2003; Jameson, 2005; Martin et al., 2006), 
This was not a nonspecific effect because expression of CD4 
by polyclonal B6 T cells was unaffected (Fig. 7 a). Furthermore, 
Figure 7.  Increased transcription of CD8 gene after deprived of 
MHC-I contact. Spleen cells from B6 (a) OT-I (a) and E8I-CD4 transgenic 
mice (c) were cultured for 24 h in the absence (control) or presence of anti-
Kb and anti-Db antibodies. In (a), the data show expression levels of CD4  
(on CD4 T cells), CD8 and CD8 (on CD8 T cells). Expression of indicated 
molecules is presented as fluorescence intensity relative to the control cul-
tures. (b) OT-I cells were cultured as in a, except that actinomycin D (AMD) 
or cycloheximide (CHX) were added to some cultures, as indicated. Expres-
sion of indicated molecules is presented as fluorescence intensity relative  
to control cultures. (c) E8I-CD4 splenocytes were analyzed as in a, except 
that CD4 levels were monitored on both CD48- T cells (first panel, reflecting 
endogenous CD4) and on CD48+ T cells (reflecting transgene encoded CD4). 
For a–c, the data represent mean ± SD. (d) Splenocytes from OT-I Tg mice 
(Thy1.1) were cultured for 24 h in the presence or absence of anti-Kb and 
anti-Db antibodies, and then transferred into B6 mice (n = 3 mice/group). 
CD8 and CD8 expression levels on donor OT-I cells isolated from lymph 
nodes 48 h later were determined. This CD8 and CD8 staining on OT-I 
cells from control cultures was defined as 100 for each time point. Data 
before transfer is from one sample and data at 48 h after transfer represent 
mean ± SD. All data are representative of two to three independent  
experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001.2264 Self-MHC dictates naïve T cell sensitivity by CD8 tuning | Takada and Jameson
similar requirements for self-MHC-I for their maintenance. 
Importantly, our data suggesting a role for MHC-I in the 
maintenance of polyclonal CD8 T cells contrasts with strong 
evidence for equivalent survival of CD4 T cells in MHC-II–
deficient and –sufficient hosts (under lymphoreplete condi-
tions; Clarke and Rudensky, 2000; Dorfman et al., 2000). 
TCR ablation studies also report faster decay rates for naive 
CD8 T cells versus CD4 T cells (Labrecque et al., 2001; Polic 
et al., 2001). Together with our data, these findings suggest 
distinct  requirements  for  TCR-mediated  survival  signals 
within the naive CD4 and CD8 populations.
By use of distinct BM chimeric hosts, we unexpectedly 
found a differential role of MHC-I expressed on hematopoi-
etic and nonhematopoietic cells. Although MHC-I expres-
sion in either compartment appeared sufficient to mediate 
normal CD8 T cell survival, changes in CD8 expression level 
were more marked when MHC-I was lacking on radioresis-
tant cells (Fig. 3). Furthermore, at short time points, pheno-
typic  and  functional  aspects  of  CD8  tuning  were  more 
apparent in lymph nodes than in spleen (Fig. 5, a and c). At 
steady state, T cells are thought to migrate within the T cell 
zones of secondary lymphoid organs along a network formed 
by nonhematopoietic stromal cells (Bajénoff et al., 2006),   
and it was recently reported that IL-7 is mainly produced   
by fibroblastic reticular stromal cells (gp38+CD31CD35) 
in T cell zones of secondary lymphoid organs (Link et al., 
2007). It is interesting to speculate that such radioresistant 
stromal cells may offer both IL-7 and self-peptide–MHC-I 
molecules to circulating CD8 T cells, and thus regulate the 
T cell’s tuning.
Previous studies on the impact of self-MHC molecules 
on T cell sensitivity have yielded strikingly divergent results. 
Because of the issues with CD8 T cell rejection discussed, 
such studies have mostly focused on CD4 T cells. Published 
works indicated that MHC-II–deprived CD4 T cells have 
elevated  (Bhandoola  et  al.,  2002;  Smith  et  al.,  2001)  or   
diminished (Stefanová et al., 2002) sensitivity to antigen, or 
that intrinsic antigen sensitivity is intact in such cells, but 
their in vivo reactivity is impaired because of lost motility 
(Fischer et al., 2007). These studies varied in their use of 
lymphopenic hosts, but also covered a range of time points 
(from hours to months) in the analysis of CD4 T cell sensitiv-
ity. Therefore, it was possible that the discrepancies between 
the  studies  could  be  explained  by  suggesting  that  MHC   
deprivation caused initial desensitization of T cell sensitivity 
(involving  lost  basal  TCR  signaling  and  polarization   
of TCR), followed by a compensatory retuning (involving 
reduced CD5 expression) allowing for improved functional 
sensitivity (Hogquist et al., 2003). Although such a model 
may still apply to CD4 T cells, our data with CD8 T cells 
suggest a distinct model, in that MHC-I deprivation (whether 
for 2 h, 24 h, or 14 d) did not impact sensitivity to strong   
agonist peptide–MHC ligands in vitro or in vivo (Fig. 4, b–e). 
However, sensitivity to weak agonist ligands, assessed in   
vitro, was enhanced after MHC-I deprivation for as little as 24 h 
(Fig. 5 c), and this increased reactivity was maintained for   
these studies must be interpreted with care. Alternative ap-
proaches have used TCR ablation by genetic means, includ-
ing cre-lox TCR gene deletion (Polic et al., 2001) and tet 
regulatable  TCR  transgene  expression  (Labrecque  et  al., 
2001). However, conclusions from these studies are also com-
plicated because T cell development is terminated in such sys-
tems, and because these approaches test the role of the TCR 
itself, rather than its encounter with self-MHC molecules, 
during T cell maintenance. In the current study, we make use 
of established radiation BM chimeras and short-term adop-
tive transfer experiments to examine how the presence of 
MHC-I impacts CD8 T cell maintenance under lymphore-
plete conditions.
Our data on naive CD8 T cell survival in the absence   
of classical MHC-I molecules suggest a much more gradual 
decline than has previously been reported. We find that the 
CD8 T cell half-life changed from 21 to 10 d in WT 
versus KbDb/ hosts, respectively. Earlier studies reported 
fast  decay  rates  in  MHC-I–deficient  hosts,  with  almost   
complete disappearance of donor CD8 T cells by 2–14 d 
(Tanchot et al., 1997; Markiewicz et al., 1998, 2003; Hao   
et al., 2006). However, such studies were conducted in lym-
phopenic hosts that would allow at least some CD8 T cells to 
undergo efficient homeostatic proliferation in the WT host. 
In addition, most previous studies used MHC-I–expressing 
donor CD8 T cells in their studies, which would allow for 
MHC-I recognition after T–T interactions. The absence of 
CFSE dye dilution in any of the hosts in our study rules out 
homeostatic proliferation as a basis for their improved main-
tenance in MHC-I–sufficient hosts, but the basis for naive 
CD8 T cell decline in MHC-I–deficient hosts is not yet clear. 
Interestingly,  we  observed  a  reduced  expression  of  the   
IL-7R chain (CD127) on MHC-I–deprived CD8 T+ cells. 
Because IL-7 is a critical survival factor for naive T cells 
(Akashi  et  al.,  1997;  Jameson,  2002,  2005;  Marrack  and   
Kappler,  2004;  Surh  and  Sprent,  2005),  reduced  CD127   
levels may suggest decreased survival potential. This interpre-
tation is complicated, however, by the finding that CD127 
expression is reduced after its engagement by IL-7 (Park et 
al., 2004), so low CD127 levels can also be a result of efficient 
IL-7 encounter. Despite the more rapid decay rate of CD8 T 
cells in MHC-I–deficient environments, a small number of 
CD8 T cells clearly survived as late as 60 d after transfer (Fig. 
3, a and b). This could be caused by a uniform decay rate of 
the entire population or reflect variability in the requirement 
for MHC-I recognition, such that some clones are highly 
sensitive to MHC-I deprivation, whereas others are indepen-
dent of self-MHC-I ligands. In our studies using OT-I T 
cells, we noted that their survival was equivalent by day 14 
after transfer into MHC-I–deficient and control hosts (un-
published data), suggesting that not all clones follow the same 
decay kinetics. However, analysis of TCR V usage could 
not demonstrate a significant bias in the overall repertoire of 
polyclonal CD8 T cells persisting to day 20 after transfer into 
WT versus KbDb/ hosts. Nevertheless, further studies will 
be required to determine whether all CD8 T cells exhibit JEM VOL. 206, September 28, 2009 
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et al., 1988; Park et al., 2007). Hence, our data suggest that 
loss of encounter with self-MHC-I molecules causes naive 
CD8 T cells to increase transcription and surface expression 
of CD8.
Our data also indicated that “tuning” of CD8 levels was 
reversible: CD8 T cells deprived of encounter with MHC 
class I up-regulated CD8, but upon reexposure to a normal 
environment CD8 expression levels were restored to normal 
(Fig. 7 d). This capacity for “retuning” CD8 expression levels 
might affect our ability to determine functional consequences 
of MHC-I deprivation. As shown in (Fig. 5, g and h), MHC-I 
deprivation  led  to  enhanced  early  functional  responses   
(induction of CD69, pc-Jun) but no changes in proliferation, 
in response to G4/Kb. However, because these assays must 
(to be physiologically relevant) involve exposure of respond-
ing T cells to MHC-I molecules, retuning may occur during 
the assay, complicating interpretation of later responses (in-
cluding proliferation). Analysis of other early activation events 
is complicated by the inability of G4/Kb to induce detectable 
proximal  activation  in  OT-I  cells  (Rosette  et  al.,  2001).   
Although further studies will be needed to explore this con-
cept further, these data suggest that CD8 T cells might con-
stantly fine-tune their CD8 expression levels to match their 
recent encounter with self-peptide–MHC class I ligands.
The capacity of mature CD8 T cells to regulate their   
ligand  binding  and  functional  reactivity  by  dynamic  “co-
  receptor tuning” has become clear over recent years (Maile   
et al., 2005; Park et al., 2007; Xiao et al., 2007). Singer’s 
group showed that responsiveness to IL-7 enhances CD8a 
transcription, and that this pathway is blocked by TCR en-
counter with strong agonists (Park et al., 2007). Furthermore, 
terminating self-MHC interactions during thymic develop-
ment enhanced CD8 expression levels (Park et al., 2007). 
Our data extend this model of Park et al. by focusing on the 
fate of mature peripheral CD8 T cells acutely deprived of 
self-peptide–MHC-I molecules. In their work, the effect of 
IL-7 on coreceptor expression has been attributed to the ac-
tivity of one of the enhancer elements, E8I, specifically used 
in mature CD8 T cells (Park et al., 2007). It is interesting to 
note the fact that enhanced transcriptional regulation of the 
E8I-CD4 reporter system was seen in response to both en-
counter with IL-7 (Park et al., 2007) and MHC-I deprivation 
(Fig. 7 c). Whether both systems involve the same elements 
within the CD8a promoter or E8I enhancer is not clear, but 
it is tempting to speculate that the regulatory processes could 
be overlapping. Our data showed that terminating the inter-
action with MHC-I ligands led to elevated CD8 expression, 
but decreased IL-7R expression (Figs. 2 c, 5 a, and S2). As 
discussed earlier, impaired IL-7R expression is difficult to in-
terpret, because it may arise by either reduced IL-7R expres-
sion  or  elevated  IL-7R  signaling—both  of  which  would 
involve decreased CD127 transcription and expression. Our 
data might indicate that deprivation of the basal interaction 
with self-MHC-I directly leads to impaired CD127 expres-
sion, which is an interesting contrast to the impact of strong 
TCR signals, which also leads to loss of CD127 expression. 
at least 2 wk (Fig. 4 c). Although we could confirm and extend 
previous works suggesting self-MHC deprivation results in 
decreased CD5 levels (Figs. 4 a and 5 a; Smith et al., 2001), 
our data also indicated that the functionally relevant change is 
enhanced CD8 expression. We observed a modest, but repro-
ducible, increase in CD8 expression by OT-I cells in KbDb/ 
hosts, which correlated with their improved reactivity to-
ward the weak agonist G4/Kb (Fig. 5, a and c), and could 
demonstrate  that  mild  blockade  of  CD8  expression  levels   
restored G4/Kb reactivity (Fig. 6 and Fig. S4), supporting   
the model that CD8 fine tuning can explain the differential 
reactivity to low-affinity peptide–MHC ligands.
The observation that MHC-I–deprived OT-I T cell re-
sponsiveness to the strong agonist OVA/Kb was not affected 
even at low doses is consistent with a selective role for CD8 
tuning in qualitative regulation of low-affinity TCR ligands. 
CD8 plays an important role in TCR binding and reactivity 
for peptide–MHC ligands, but this is more profound for low-
affinity ligands (Holler and Kranz, 2003; Holman et al., 2005; 
Maile et al., 2005). Furthermore, some data suggest the sta-
bility of low-affinity TCR interactions required for thymic 
positive selection is highly dependent on CD8 (Daniels et al., 
2006). Hence, our data are consistent with the model that 
MHC-I deprivation causes a compensatory change in CD8 
levels, as the cells “cast around” for the low-affinity self-peptide–
MHC ligands that sustain their basal TCR signaling.
Initially, it might appear our data contradict studies show-
ing that engagement with nonstimulatory peptide–MHC li-
gands (including self-peptide–MHC molecules) can enhance 
CD8 T cell responses to agonist ligands (Micheletti et al., 
2000; Cebecauer et al., 2005; Yachi et al., 2005, 2007). 
However,  our  studies  explore  how  MHC-I  deprivation   
affects subsequent CD8 T cell responses, whereas those pre-
vious works test effects of simultaneous exposure to agonist 
and  “coagonist”  ligands.  Indeed,  because  our  functional   
studies use WT APCs (expressing the normal array of self-
peptide–MHC ligands), it is quite feasible that the enhanced 
sensitivity we observe in the response to low-affinity agonists 
actually  reflects  enhanced  recognition  of  self-coagonist   
ligands. Along these lines, it is worth noting that the cooper-
ative effect of coagonists is most pronounced in the response 
to low affinity agonists and at early time points during activa-
tion  (Yachi  et  al.,  2007),  similar  to  our  observations  for 
MHC-I–deprived  CD8  T  cells.  It  will  be  interesting  to   
explore this model in future studies.
The mechanism by which MHC-I deprivation resulted 
in CD8 up-regulation was also explored. Our data revealed 
that blockade of MHC-I molecules lead to increased tran-
scriptional activity at the CD8a gene, as revealed by use of 
transcriptional  inhibitors  and  the  E8I-CD4  reporter  strain 
(Fig. 7, b and c). CD8 is also elevated on MHC-I deprived 
CD8 T cells, and it is possible that this is also regulated tran-
scriptionally. However, previous studies have shown that the 
requirement for mouse CD8b to associate with CD8 for 
surface  expression  leads  to  CD8  expression  levels  being 
strongly dependent on the expression level of Cd8a (Gorman 2266 Self-MHC dictates naïve T cell sensitivity by CD8 tuning | Takada and Jameson
In vivo priming of OT-I cells. Host mice were injected i.v. with 3 × 106 
WT OT-I or KbDb/ OT-I donor cells. DCs were enriched from the 
spleen cell pool obtained from normal WT mice using anti-CD11c magnetic 
beads as previously described (Fischer et al., 2007). Enriched DCs were 
pulsed with 10 nM OVAp (SIINFEKL) for 1 h at 37°C. After an intensive 
wash, 106 I-A+CD11c+ cells were injected i.v. into mice pretransferred 
with OT-I cells. Control mice were given nonpulsed DCs. Spleens and 
lymph nodes were obtained from host mice 18 h following DC transfer, and 
the phenotype of CD8 cells reactive with Kb-OVAp tetramer was analyzed 
by flow cytometry.
In vitro activation assay. WT OT-I (Thy1.1) or CFSE-labeled KbDb/ 
OT-I cells were adoptively transferred at 3–5 × 106/mouse. Spleen cells or 
lymph node cells harvested from hosts were placed in 96-well plate at 2 × 
106/well with the half number of irradiated (2500 rads) WT spleen cells 
pulsed with various peptides, including -Cat, G4, N6 (10 µM) or OVAp 
(10 nM; Hogquist et al., 1994; Jameson et al., 1993; Santori et al., 2002). 
For mixed stimulation experiments (Fig. 5, g and h), donor OT-I cells   
with different congenic markers (Thy1.1+Thy1.2+ and Thy1.1+Thy1.2-) 
were transferred at 4–5 × 106/mouse. Lymph node cells from each group of 
hosts  and  irradiated  WT  splenocytes  were  mixed  at  equal  number  and 
placed in 48-well plate at 6 x106/well with or without G4 (103 nM). In 
some experiments, freshly isolated WT naive OT-I cells were similarly 
stimulated and analyzed. The OT-I response was measured at 6 h (for 
CD69 and pc-Jun assays) or 48 h (for CFSE dye dilution assays) after initia-
tion of the cultures. For CD8 blockade experiments, OT-I cells (from indi-
cated sources) were cultured with anti-CD8 antibody (53–5.8; BD) or 
anti-CD8 antibody (53–6.7) at the indicated doses. After 30 min incuba-
tion (at room temperature), the OT-I cells were mixed with B6 splenocytes 
which were pulsed with G4 or OVAp peptides (or unpulsed). At 6 h,   
OT-I cells were stained for available CD8 and CD8 expression (deter-
mined by staining with fluorescent 53–5.8 or 53–6.7 antibodies) and   
CD69 induction.
MHC-I blocking in vitro. Spleen cells were cultured (107/ml) for 24 h in 
the presence of anti-Kb (y3) and anti-Db (28–14.8) mAb (20 µg/ml). Actino-
mycin D (5 µg/ml; Sigma-Aldrich) or cycloheximide (10 µg/ml; Sigma-
  Aldrich) was added at the initiation of the cultures where indicated. In some 
experiments, the cells were washed intensively and adoptively transferred (at 
5 × 106/mouse) to intact B6 mice (n = 3/group). Donor cells were analyzed 
from lymph nodes harvested 48 h after transfer.
Flow  cytometry.  Single-cell  suspensions  were  prepared  from  spleen   
and lymph nodes by mechanical disruption. Cells were resuspended in 
phosphate-buffered saline (pH 7.4) plus 1% fetal calf serum and incubated 
with fluorochrome-labeled mAbs. Antibodies with the following specifici-
ties were used for analysis: CD4 (L3T4), CD8 (53–6.7), CD8 (53–5.8; 
BD);  B220  (RA3-6B2),  CD5  (53–7.3),  CD44  (IM7),  CD45.1  (A20), 
CD62L (MEL-14), CD69 (H1.2F3), IL-7 receptor  (IL-7R; A7R34), 
TCR  (H57-597), and Thy1.1 (HIS51; eBioscience). TCR V reper-
toire analysis was performed using a TCR V Screening Panel kit from 
BD. Biotinylated monomeric OVAp/Kb was prepared as previously de-
scribed (Kao et al., 2005), and mixed with allophycocyanin-conjugated 
streptavidin (Invitrogen) at an 8:1 molar ratio (1:1 mass ratio), followed by 
incubation at room temperature for 1 h before staining. Staining of phos-
phorylated  c-Jun  followed  the  previously  described  protocol  (Rosette   
et  al.,  2001),  sequentially  using  purified  anti–phospho-serine  63-c-Jun 
(KM1; Santa Cruz Biotechnology, Inc.), biotin-conjugated anti–mouse 
IgG1 (A85-1; BD), and streptavidin-phycoerythrin (BD). For intracellular 
staining of TNF, cells were stimulated with peptides in the presence of 
GolgiStop (BD). 6 h later, cells were treated with Cytofix/Cytoperm (BD) 
after surface staining, and were reacted with anti-TNF (MP6-XT22; BD) 
mAb. CFSE dye dilution was assessed in the FL-1 channel. Data were   
collected by FACSCalibur or LSR II instruments (BD) and analyzed on 
FlowJo software (Tree Star, Inc.).
Further  studies  will  be  required  to  investigate  whether   
prolonged loss of self-MHC encounters directly lead to   
reduced expression of IL-7R, and whether this in turn   
accounts for the impaired long term survival of CD8 T 
cells in KbDb/ hosts.
In conclusion, we show the first evidence that self-
  peptide–MHC-I complexes are required for efficient sur-
vival of polyclonal CD8 T cells in lymphoreplete hosts. At 
the same time, self-peptide–MHC-I encounter also impairs 
CD8  T  cell  responsiveness  toward  low-affinity  peptide–
MHC antigens through down-regulation of CD8, which 
may contribute to maintenance of T cell tolerance. These 
findings differ substantially from those observed for mainte-
nance  of  CD4  T  cells,  suggesting  fundamentally  distinct 
roles of self-peptide–MHC ligands in regulating the two   
T cell subsets.
MATERIALS AND METHODS
Mice. WT C57BL/6 (B6; CD45.2, Thy1.2), B6.SJL (CD45.1), and B6.PL 
(Thy1.1) mice were obtained from the National Cancer Institute (Frederick, 
MD) or The Jackson Laboratory. H-2Kb/H-2Db/ (KbDb/) mice were 
originally purchased from Taconic Farms and intercrossed with B6.PL ani-
mals (The Jackson Laboratory) to produce Thy1.1 congenic KbDb/ mice. 
OT-I mice were intercrossed with B6.PL mice to generate Thy-1.1 homo-
zygous and Thy-1.1/-1.2 heterozygous mice. KbDb/ Rag/ OT-I TCR 
transgenic mice were originally obtained from E. Schott and H. Ploegh 
(Massachussetts Institute of Technology, Cambridge, MA). Lymphoid tissues 
from E8I-CD4 Tg mice were provided by A. Singer and T. McCaughtry 
(National Institutes of Health, Bethesda, MD). All mouse strains were bred 
and maintained under specific pathogen–free conditions. Experiments were 
performed with approval from the Institutional Animal Care and Use Com-
mittee at the University of Minnesota.
BM  chimeras.  BM  cells  were  depleted  of  T  cells  by  incubation  with   
anti-Thy1.2 (30H12) or anti-Thy1.1 (IA14) monoclonal antibodies (mAb) 
and rabbit complement (Cedarlane Laboratories). More than 107 cells were 
injected  i.v.  into  lethally  irradiated  (1,000  rads)  mice.  Recipients  were   
injected i.p. with anti-NK1.1 mAb (PK136) on the day before (50 µg), and 
7 and 14 d (25 µg) after the transfer of BM cells (Schott et al., 2003). Chime-
ras were used for experiments at least 10 wk after BM transfusion. In all 
KbDb/ → WT and WT → KbDb/ chimeras used as recipients, >95% of 
reconstituted blood cells were donor derived.
Purification of donor cells. Spleens and systemic lymph nodes (axially, 
inguinal, mesenteric, and salivary) were extracted from donors. MHC-I–
  deficient donor cells were prepared from KbDb/ → WT (CD45.1) or 
KbDb/Rag/OT-I Tg → WT (CD45.1) BM chimeras by purifying BM 
donor-derived lymphocytes by negative selection using FITC-conjugated 
anti-CD45.1 (BioLegend) mAb with anti-FITC magnetic beads following 
the manufacturer’s directions (Miltenyi Biotec). In some experiments, B cells 
were also depleted by anti-B220 mAb (eBioscience). Resulting cells rou-
tinely contained <2% of Kb+ or CD45.1+ cells. Polyclonal WT donor lym-
phocytes for survival studies were obtained from B6 mice and used without 
further purification, and WT OT-I cells for functional studies were purified 
from OT-I Tg mice by depleting cells using anti-CD4, anti-B220, and anti-
I-Ab mAb (BD) and magnetic beads (Miltenyi Biotec).
Survival studies. Lymphocytes were stained with CFSE (Invitrogen) as 
described previously (Prlic et al., 2003), and 5 × 106 cells were injected into 
indicated host mice. The frequency of CFSE+ CD44lo cells in the spleen and 
lymph nodes of hosts were analyzed by flow cytometry. In some experi-
ments, Thy1.1+ T cells were transferred (3–5 × 106/mouse) and detected by 
the congenic marker.JEM VOL. 206, September 28, 2009 
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